http://www.sangamo.com
Sangamo Therapeutics, Inc. Company Intro
Sangamo uses a multi-platform approach to gene-based therapeutics with industry leading technologies in gene therapy, gene editing, cell therapy and gene regulation. Meet the leaders and learn more about Sangamo's latest developments.
Industry
Healthcare
Sangamo Therapeutics, Inc. Headquaters
7000 Marina Boulevard
Brisbane,94005
United States
Sangamo Therapeutics, Inc. Share price
29 Jun 2022 13:55 GMT
$4.0400
-0.05 (-1.22 %)
Sangamo Therapeutics, Inc. Market cap
$596.539 M
WMC RANKING
2022
Sangamo Therapeutics, Inc. # 58
BiotechnologyLatest Sangamo Therapeutics, Inc. News
25 Jun 2022
Savara Inc. (NASDAQ: SVRA) - Does It Provide Stability And ...
On the other hand, the price of Sangamo Therapeutics Inc. (SGMO) has fallen -1.37% on the day. The stock, however, is off -63.47% from where it was a year...
25 Jun 2022
Genetic Engineering Market Investment Analysis | Horizon ...
... Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs, Sangamo Therapeutics, Inc., GenScript, Thermo Fisher Scientific Inc., Amgen Inc.,...
WMC Market Score
WMC Market to Revenue Score
Sangamo Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Sangamo Therapeutics, Inc. | USD | $131,396 | $262,728 | $-124,016 | $5,965M | 58 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $637,790B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $710,140B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $167,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Sangamo Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Sangamo Therapeutics, Inc. Post vs Top 4 Industry Competitors
Sangamo Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Sangamo Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Sangamo Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Sangamo Therapeutics, Inc. | 1.43 | 2.03 | 0.05 | 0 | 0 | 0 | 0.93 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 0 | 0 | 0 | 20.12 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
